Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Vitamin A Deficiency

  • Author: George Ansstas, MD; Chief Editor: George T Griffing, MD  more...
 
Updated: Jun 10, 2014
 

Background

The word vitamin was originally derived from Funk's term "vital amine." In 1912, he was referring to Christian Eijkman's discovery of an amine extracted from rice polishings that could prevent beriberi. Funk's recognition of the antiberiberi factor as vital for life was indeed accurate. Researchers have since found that vitamins are essential organic compounds that the human body cannot synthesize. Vitamins A, D, K, and E are classified as fat-soluble vitamins, whereas others are classified as water-soluble vitamins.[1, 2]

See 21 Hidden Clues to Diagnosing Nutritional Deficiencies, a Critical Images slideshow, to help identify clues to conditions associated with malnutrition.

Vitamin A was the first fat-soluble vitamin to be discovered. Early observations by ancient Egyptians recognized that night blindness could be treated with consumption of liver. Two independent research teams, Osborne and Mendel at Yale University and McCollum and Davis at the University of Wisconsin, simultaneously discovered vitamin A in 1913. Vitamin A is made up of a family of compounds called the retinoids. The retinoid designation resulted from finding that vitamin A had the biologic activity of retinol, which was originally isolated from the retina.

There are essentially 3 forms of vitamin A: retinols, beta carotenes, and carotenoids. Retinol, also known as preformed vitamin A, is the most active form and is mostly found in animal sources of food. Beta carotene, also known as provitamin A, is the plant source of retinol from which mammals make two-thirds of their vitamin A. Carotenoids, the largest group of the 3, contain multiple conjugated double bonds and exist in a free alcohol or in a fatty acyl-ester form.

In the human body, retinol is the predominant form, and 11-cis -retinol is the active form. Retinol-binding protein (RBP) binds vitamin A and regulates its absorption and metabolism. Vitamin A is essential for vision (especially dark adaptation), immune response, bone growth, reproduction, the maintenance of the surface linings of the eyes, epithelial cell growth and repair, and the epithelial integrity of the respiratory, urinary, and intestinal tracts. Vitamin A is also important for embryonic development and the regulation of adult genes. It functions as an activator of gene expression by retinoid alpha-receptor transcription factor and ligand-dependent transcription factor.

Deficiency of vitamin A is found among malnourished, elderly, and chronically sick populations in the United States, but it is more prevalent in developing countries. Abnormal visual adaptation to darkness, dry skin, dry hair, broken fingernails, and decreased resistance to infections are among the first signs of vitamin A deficiency (VAD).[3]

Recent studies

In a Venezuelan study, Jimenez et al investigated the effect of a single, oral 200,000 IU dose of vitamin A on iron and vitamin A nutritional status, the phagocytic function of neutrophils, and the rate of anemia, in a population of preschool children with a high prevalence of VAD. The study group consisted of 80 children, including 12 controls; no iron supplementation was provided.

In an assessment of the children 30 days after the administration of vitamin A, the authors found that those who had received the supplement exhibited a significant increase in concentrations of hemoglobin (Hb), mean corpuscular Hb, and serum retinol, while the rates of anemia and VAD among the children fell from 17.6% to 13.2% and from 25% to 13.2%, respectively. In addition, the phagocytic capacity of neutrophils increased in the supplement group. The authors concluded that vitamin A supplementation could help to decrease the frequency of VAD and anemia, as well as to increase the immune response, in preschool children.[4]

Next

Pathophysiology

Once ingested, provitamins A are released from proteins in the stomach. These retinyl esters are then hydrolyzed to retinol in the small intestine, because retinol is more efficiently absorbed. Carotenoids are cleaved in the intestinal mucosa into molecules of retinaldehyde, which is subsequently reduced to retinol and then esterified to retinyl esters. The retinyl esters of retinoid and carotenoid origin are transported via micelles in the lymphatic drainage of the intestine to the blood and then to the liver as components of chylomicrons. In the body, 50-80% of vitamin A is stored in the liver, where it is bound to the cellular RBP. The remaining vitamin A is deposited into adipose tissue, the lungs, and the kidneys as retinyl esters, most commonly as retinyl palmitate.

Vitamin A can be mobilized from the liver to peripheral tissue by a process of deesterification of the retinyl esters. In blood, vitamin A is bound to RBP, which transports it as a complex with transthyretin. The hepatic synthesis of RBP is dependent on the presence of zinc and amino acids to maintain its narrow serum range of 40-50 mcg/dL. Through a receptor-mediated process, the retinol is taken up by the peripheral tissues from the RBP-transthyretin complex.

VAD may be secondary to decreased ingestion, defective absorption and altered metabolism, or increased requirements. An adult liver can store up to a year's reserve of vitamin A, whereas a child's liver may have enough stores to last only several weeks. Serum retinol concentration reflects an individual's vitamin A status. Because serum retinol is homeostatically controlled, its levels do not drop until the body's stores are significantly limited. The serum concentration of retinol is affected by several factors, including RBP synthesis in the liver, infection, nutritional status, and the existing level of other nutrients, such as zinc and iron.[5]

In zinc deficiency, impaired synthesis of proteins occurs with rapid turnover (eg, RBP). In turn, this impairment affects retinol transport by RBP from the liver to the circulation and to other tissues. The mechanism by which iron affects vitamin A metabolism has not been identified, but randomized, double-blind studies have shown that vitamin A supplementation alone is not sufficient to improve VAD in the presence of coexisting iron deficiency.

The bioavailability of the carotenoids varies; this availability depends on absorption and on their yield of retinol. Only 40-60% of ingested beta carotene from plant sources is absorbed by the human body, whereas 80-90% of retinyl esters from animal proteins are absorbed. Carotenoid absorption is affected by dietary factors, including zinc deficiency, abetalipoproteinemia, and protein deficiency.

Because vitamin A is a fat-soluble vitamin, any GI diseases affecting the absorption of fats also affect vitamin A absorption. Patients with cystic fibrosis, sprue, pancreatic insufficiency, inflammatory bowel disorder (IBD), or cholestasis, as well as persons who have undergone small-bowel bypass surgery, are at increased risk for VAD. These patients should be advised to consume vitamin A.

One factor affecting the metabolism of vitamin A is alcoholism. Alcohol dehydrogenase catalyzes the conversion of retinol to retinaldehyde, which is then oxidized to retinoic acid. The affinity of alcohol dehydrogenase to ethanol impedes the conversion of retinol to retinoic acid.

Increased requirements of vitamin A most commonly occur among sick children. The American Academy of Pediatrics has recommended vitamin A supplementation for infants aged 6-24 months who are hospitalized with measles and for all hospitalized children older than 6 months. In the 1960s, the World Health Organization (WHO) undertook the first global survey of VAD with associated xerophthalmia and complicated measles.[6] In 1973, an international vitamin A board was set up to alleviate global malnutrition.

The WHO and the United Nations International Children's Emergency Fund (UNICEF) have issued joint statements recommending that vitamin A be administered to all children, especially those younger than 2 years, who are diagnosed with measles. Coexistent VAD in young children increases the risk of death. A Cochrane Database of Systematic Reviews article concluded that daily treatment with 200,000 IU of vitamin A for at least 2 days reduces mortality rates.[7, 8]

A more recent Cochrane Database of Systematic Reviews article, including 43 randomized trials representing 215,633 children, provides strong support for the importance of vitamin A supplementation in preventing childhood mortality.[9]

Pregnant women do not require increased vitamin A supplementation. In fact, the Teratology Society advocates that women be informed of the possible risk of cranial neural crest defects and other malformations resulting from excessive use of vitamin A shortly before or during pregnancy.[10] The recommended daily allowance (RDA) of 800 mcg for all adult females is also appropriate for pregnant women, because their stores of vitamin A meet the fetal accretion rate. The requirements for lactating women have been debated, but the current RDA is 1300 mcg in the first 6 months and 1200 mcg in the second 6 months.

The RDAs of vitamin A for various age groups are as follows:

  • Infants aged 1 year or younger - 375 mcg
  • Children aged 1-3 years - 400 mcg
  • Children aged 4-6 years - 500 mcg
  • Children aged 7-10 years - 700 mcg
  • All males older than 10 years - 1000 mcg
  • All females older than 10 years - 800 mcg
Previous
Next

Epidemiology

Frequency

United States

Statistics from the US Centers for Disease Control and Prevention, based on a 1988-1991 survey, showed that age-specific intakes of carotenes were higher among males than females during that period and were higher among adults than children.[11] Significant differences in intake existed among different ethnic groups.

International

Clinical and subclinical VAD are problems in at least 75 countries.[12] In 1994, the WHO classified countries as having clinical or subclinical, severe, moderate, or mild VAD. Clinical VAD (in which children demonstrate ophthalmic signs and symptoms, including blindness) occurs mainly in countries in Southeast Asia and sub-Saharan Africa.[6] Severe VAD is also found in persons in refugee settlements and in displaced populations.[13, 14, 15]

Mortality/Morbidity

United States

VAD is uncommon in the general population, but subgroups of patients suffering from fat malabsorption, cholestasis, or IBD or who have undergone small-bowel bypass may have subclinical deficiency with dark-adaptation abnormalities in the range of 60%. Vegans, persons with alcoholism, toddlers and preschool children living below the poverty line, and recent immigrants or refugees from developing countries all have increased risk of VAD secondary to decreased ingestion.

Developing countries

An estimated 250 million children are at risk for vitamin deficiency syndromes. The most widely affected group includes up to 10 million malnourished children, who develop xerophthalmia and have an increased risk of complications and death from measles. Each year, 250,000-500,000 children become blind because of VAD. Improving the vitamin A status of children with deficiencies (aged 6-59 mo) can reduce measles and diarrhea mortality rates by 50% and 33%, respectively, and can decrease risk rates from all causes of mortality by 23%. Routine distribution of vitamin A to children in endemic areas leads to a decrease of childhood mortality of 5-15%. A meta-analysis that included the DEVTA trial and eight other trials resulted in a modest mortality reduction of 11%.[16]

Previous
 
 
Contributor Information and Disclosures
Author

George Ansstas, MD Instructor of Medicine, Attending Physician in Leukemia and Bone Marrow Transplant and Oncology, Washington University School of Medicine

George Ansstas, MD is a member of the following medical societies: American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Jigna Thakore, MD Fellow, Department of Gastroenterology, Dayton Veterans Administration Medical Center

Jigna Thakore, MD is a member of the following medical societies: American College of Gastroenterology, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

N Gopalswamy, MD Chairman, Professor of Internal Medicine, Department of Gastroenterology, Wright State University, Boonshoft School of Medicine, Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Romesh Khardori, MD, PhD, FACP Professor of Endocrinology, Director of Training Program, Division of Endocrinology, Diabetes and Metabolism, Strelitz Diabetes and Endocrine Disorders Institute, Department of Internal Medicine, Eastern Virginia Medical School

Romesh Khardori, MD, PhD, FACP is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians, American Diabetes Association, Endocrine Society

Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD Professor Emeritus of Medicine, St Louis University School of Medicine

George T Griffing, MD is a member of the following medical societies: American Association for the Advancement of Science, International Society for Clinical Densitometry, Southern Society for Clinical Investigation, American College of Medical Practice Executives, American Association for Physician Leadership, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical and Translational Research, Endocrine Society

Disclosure: Nothing to disclose.

References
  1. Combs GF Jr. Vitamins. Mahan LK, Escott-Stump S, eds. Krause's Food, Nutrition, and Diet Therapy. 10th ed. Philadelphia, Pa: WB Saunders; 2000.

  2. Pazirandeh S, Burns DL. Overview of fat-soluble vitamins I. UpToDate. 2002.

  3. Russell RM. Vitamin and trace mineral deficiency and excess. Braunwald E, Fauci A, Kasper D, et al, eds. Harrison's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001. vol 1: 465-6.

  4. Jimenez C, Leets I, Puche R, et al. A single dose of vitamin A improves haemoglobin concentration, retinol status and phagocytic function of neutrophils in preschool children. Br J Nutr. 2009 Dec 15. 1-5. [Medline].

  5. Munoz EC, Rosado JL, Lopez P, et al. Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers. Am J Clin Nutr. 2000 Mar. 71(3):789-94. [Medline]. [Full Text].

  6. Reddy V. History of the International Vitamin A Consultative Group 1975-2000. J Nutr. 2002 Sep. 132(9 Suppl):2852S-6S. [Medline]. [Full Text].

  7. D'Souza RM, D'Souza R. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2002. (1):CD001479. [Medline].

  8. Gungor S, Olmez A, Pinar Arikan Firat, et al. Serum retinol and beta-carotene levels in subacute sclerosing panencephalitis. J Child Neurol. 2007 Mar. 22(3):341-3. [Medline].

  9. Imdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. Cochrane Database Syst Rev. 2010 Dec 8. 12:CD008524. [Medline].

  10. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995 Nov 23. 333(21):1369-73. [Medline]. [Full Text].

  11. Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data. 1994 Nov 14. 1-28. [Medline]. [Full Text].

  12. Lee V, Ahmed F, Wada S, et al. Extent of vitamin A deficiency among rural pregnant women in Bangladesh. Public Health Nutr. 2008 Jun 12. 1-6. [Medline].

  13. West KP Jr, Mehra S. Vitamin A intake and status in populations facing economic stress. J Nutr. 2010 Jan. 140(1):201S-7S. [Medline].

  14. Semba RD, de Pee S, Sun K, et al. The role of expanded coverage of the national vitamin A program in preventing morbidity and mortality among preschool children in India. J Nutr. 2010 Jan. 140(1):208S-12S. [Medline].

  15. Williams IO, Essien EU, Eka OU. Socioeconomic Factors and Vitamin A Status of Pregnant Women in Calabar Urban, Southeastern Nigeria. Matern Child Health J. 2009 Nov 25. [Medline].

  16. Awasthi S, Peto R, Read S, Clark S, Pande V, Bundy D. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet. 2013 Apr 27. 381(9876):1469-77. [Medline].

  17. Al-Saleh I, El-Doush I, Billedo G. Age and gender-related reference values for serum dl-alpha-tocopherol and all-trans-retinol levels in Saudi population. Int J Vitam Nutr Res. 2007 Sep. 77(5):326-35. [Medline].

  18. Gomes MM, Saunders C, Ramalho A. Placenta: a possible predictor of vitamin A deficiency. Br J Nutr. 2009 Dec 15. 1-5. [Medline].

  19. de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr. 2002 Sep. 132(9 Suppl):2895S-901S. [Medline]. [Full Text].

  20. Weinman AR, Jorge SM, Martins AR, et al. Assessment of vitamin A nutritional status in newborn preterm infants. Nutrition. 2007 Jun. 23(6):454-60. [Medline].

  21. Gorstein JL, Dary O, Pongtorn, et al. Feasibility of using retinol-binding protein from capillary blood specimens to estimate serum retinol concentrations and the prevalence of vitamin A deficiency in low-resource settings. Public Health Nutr. 2008 May. 11(5):513-20. [Medline].

  22. Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr. 2000 Apr. 71(4):878-84. [Medline]. [Full Text].

  23. Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011 Aug 25. 343:d5094. [Medline]. [Full Text].

  24. Dietary Guidelines for Americans, 2005. Department of Health and Human Services, Department of Agriculture. Jan 2005. Available at http://www.health.gov/dietaryguidelines/dga2005/document/default.htm.

  25. Dietary Supplement Fact Sheet: Vitamin A and Carotenoids. National Institutes of Health, Office of Dietary Supplements. Apr 23 2006. Available at http://ods.od.nih.gov/factsheets/vitamina.asp.

  26. Fletcher RH, Fairfield KM. Vitamin supplementation in disease prevention II. UpToDate. 2002.

  27. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. 2002 Jun 19. 287(23):3116-26. [Medline]. [Full Text].

  28. Willett WC, Hunter DJ. Vitamin A and cancers of the breast, large bowel, and prostate: epidemiologic evidence. Nutr Rev. 1994 Feb. 52(2 Pt 2):S53-9. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.